Last edition
News about "GIP receptor antagonism"
Antag Therapeutics Names Dr. Joerg Moeller as its Chief Executive Officer
With over 30 years of industry and leadership experience, Dr. Moeller has an impressive track record of successfully leading large global organizations and has built an expansive portfolio by driving strategic growth, regulatory compliance, and fostering innovation.
GIP Receptor Antagonism | 09/01/2025 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members